A Phase II Trial of Aprinocarsen, an Antisense Oligonucleotide Inhibitor of Protein Kinase C α, Administered as a 21-Day Infusion to Patients with Advanced Ovarian Carcinoma

Ranjana Advani, Prema Peethambaram, Bert L. Luto, George A. Fisher, Lynn Hartmann, Harry J. Long, Joanne Halsey, Jon T. Holmlund, Andrew Dorr, Branimir I. Sikic

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Trial of Aprinocarsen, an Antisense Oligonucleotide Inhibitor of Protein Kinase C α, Administered as a 21-Day Infusion to Patients with Advanced Ovarian Carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences